72-Patient Trial Fast-Tracks TRP-8803 Commercialisation
Filed with ASX · · 11 pages · English
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Trading Halt
- South Africa Grants ENP Broad Fibromyalgia Patent to 2043
- 100% Clinical improvement, 50% Remission in BED study
- DSMB Clears TRP 8803 to Advance to Cohort 2
- Entropy completes Cohort 1 dosing in BED trial
Later from Entropy Neurodynamics
- 72 patient multi-indication trial approved to fast track TRP-8803 commercialisation
- BioShares 2026 Investor Presentation Deck
- Application for quotation of securities - ENP
- Cleansing Notice
- Change of Director's Interest Notice - HJ
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics